| abstract |
The present invention relates to a method of using detection of MAL protein or genetic precursor as a marker. The marker is for the purpose of diagnosing or predicting a tumor or other pathology affecting epithelial cells, T lymphocytes, mast cells, myelin-forming cells or other types of cells, wherein the epithelial cells, T lymphocytes, mast cells In addition, the myelin-forming cells or other types of cells typically express the MAL protein (except the initial B-cell lymphoma of the media). |